Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,553 | -17,348 | N/A | N/A | N/A |
| Depreciation Amortization | -2 | N/A | N/A | N/A | N/A |
| Other Working Capital | 7,123 | 2,437 | N/A | N/A | N/A |
| Other Operating Activity | 6,070 | 14,538 | 0 | 0 | 0 |
| Operating Cash Flow | $-39,362 | $-373 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -127,500 | 0 | N/A | N/A | N/A |
| PPE Investments | -281 | -7,500 | N/A | N/A | N/A |
| Investing Cash Flow | $-127,781 | $-7,500 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 50 | N/A | N/A | N/A |
| Common Stock Issued | 67,200 | 1 | N/A | N/A | N/A |
| Other Financing Activity | 59,977 | 59,785 | 0 | 0 | 0 |
| Financing Cash Flow | $127,177 | $59,836 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -27 | 0 | N/A | N/A | N/A |
| Beginning Cash Position | 51,963 | 0 | N/A | N/A | N/A |
| End Cash Position | 11,970 | 51,963 | N/A | N/A | N/A |
| Net Cash Flow | $-39,993 | $51,963 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,362 | -373 | N/A | N/A | N/A |
| Capital Expenditure | -281 | -7,500 | N/A | N/A | N/A |
| Free Cash Flow | -39,643 | -7,873 | 0 | 0 | 0 |